WASHINGTON (dpa-AFX) - Cepheid (CPHD), a molecular diagnostics company, on Thursday reported fourth-quarter net loss of $23.8 million or $0.34 per share compared with a loss of $10.3 million or $0.15 per share last year. Analysts polled by Thomson Reuters estimated a loss of $0.13 per share for the quarter. Analysts' estimates typically exclude special items.
Excluding items, adjusted earnings for the quarter were $0.11 per share compared with earnings of $0.03 per share a year ago.
Revenues for the quarter were $131.5 million compared with $113.3 million in the prior year. Analysts estimated revenues of $125.3 million.
For the full year 2015, the company expects net loss of $0.55 to $0.51 per share, adjusted earnings of $0.19 to $0.23 per share and revenues of $538 million to $553 million.
Analysts expect a loss of $0.34 per share on revenues of $544.5 million for 2015.
Copyright RTT News/dpa-AFX
© 2015 AFX News
